GLEN ROSE MEDICAL CENTER — History
CCN 450451 | 3-year financial timeline | COVID resilience: 82/100
🛡️ Public data only — no PHI permitted on this instance.
$13M
Latest Revenue (FY2022)
+11.2%
Revenue CAGR (3yr)
-49.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $11M | $11M | $13M | +21.8% | +11.2% |
| Operating Expenses | $20M | $19M | $20M | +2.8% | +0.7% |
| Operating Margin | -82.2% | -76.9% | -49.2% | +36.0% | +0.0% |
| Net Income | $-9M | $-8M | $-7M | +22.0% | +0.0% |
| Licensed Beds | 16 | 16 | 16 | +0.0% | +0.0% |
| Total Patient Days | 651 | 912 | 743 | -18.5% | +6.8% |
| Medicare Day % | 64% | 34% | 51% | +48.4% | -11.2% |
| Medicaid Day % | nan% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 82/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +23.7% ($11M → $13M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.2%
This Hospital
+7.6%
State Avg
Latest Margin
-49.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $15M | -32.7% |
| FY2024 (proj) | $16M | -16.2% |
| FY2025 (proj) | $17M | 0.3% |